Actionable insights straight to your inbox

Equities logo

EDAP TMS Jumps on Cancer Study Success

EDAP TMS SA (EDAP), a French company that develops “minimally invasive therapeutic solutions for urology”, saw their share prices leap as much as over 34 percent on Friday to a high of $3.89